A federal appeals court ruled today that Dana-Farber can keep the $11.4 million a federal judge awarded it from a settlement pool for consumers overcharged for the cost of a prescription drug in the 1990s.
The money comes from a $40-million pool meant to reimburse consumers for the cost of Lupron, which is used to treat everything from prostate cancer to premature puberty and endometriosis.